Tumors of higher diameter (p = 0.010), those beyond the Milan criteria (p = 0.044), and female sex of the donor (p = 0.029) increased the risk of HCC recurrence independently of the pretransplant AFP level. Here, AFP is linked to hepatocellular carcinoma.